SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
Tesla Raises Cybertruck Prices by $5,000 in US 
Add as a preferred source on Google
FOR IMMEDIATE RELEASE
Fort Lauderdale, FL, April 20, 2018 -- Topstone Research, a full-service, contract research organization (CRO), has signed a new agreement with OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology. Under the agreement, Topstone will use OmniComm’s TrialMaster EDC technology to develop clinical studies at multiple Topstone research sites.
“We chose OmniComm because Topstone’s growing Data Management department is at a stage where we need to be better equipped to handle more complex trials, with a flexible and customizable EDC system,” said Muhammad Bilal, senior director-Clinical Data Management and Biostatistics at Topstone.
OmniComm was selected as one of Topstone preferred EDC systems based on TrialMaster’s inherent flexibility and broad capabilities to support clinical studies across all phases of clinical development. Deploying studies in an efficient, timely and cost-effective manner was especially important to Topstone. OmniComm’s robust, state-of-the art, compliant hosting environment was another critical factor in the selection process.
“OmniComm continues to make significant progress in the CRO market due to the speed of setup and our comprehensive suite of very robust tools,” said Kuno van der Post, Ph.D., chief commercial officer, OmniComm Systems. “We are thrilled that Topstone has selected TrialMaster to be deployed across a full spectrum of trial phases.”
About Topstone Research
Topstone Research is a specialty CRO with an unwavering commitment to quality and service flexibility. Topstone’s clinical professionals bring essential expertise to help biopharmaceutical organizations successfully solve today’s challenges in clinical research. In addition to offering a full selection of clinical trial management services, Topstone provides an unmatched and exceptional experience, from the first point of contact to final delivery. Please visit www.topstoneresearch.com for more information.
About OmniComm Systems, Inc.
OmniComm Systems provides a role in enhancing patient lives by shortening time to market of essential life-saving treatments. OmniComm Systems is dedicated to providing the latest eClinical technology enabling the world’s life science organizations to maximize the value of their clinical research investments. OmniComm’s solutions provide better trial oversight and study delivery, connecting patients to better healthcare. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. Please visit www.omnicomm.com for more information.
Trademarks
OmniComm, TrialMaster and TrialOne are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info Kuno van der Post OmniComm Systems, Inc. +1.954.473.1254 [email protected]
